Comparative Pharmacokinetics and Safety of 3 Different Formulations of TNX-102 2.8 mg SL Tablets and Cyclobenzaprine 5 mg Oral Tablet in Healthy Adults

NCT01889173 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adults

Interventions

DRUG: TNX-102 SL Tablets at 2.8 mg
DRUG: TNX-102-B SL Tablets at 2.8 mg
DRUG: TNX-102-C SL Tablets at 2.8 mg
DRUG: Cyclobenzaprine tablets

Sponsor

Tonix Pharmaceuticals, Inc.